EUVIMEDEUVIMED entdecken
Crossref

Repurposing TAK-285 as An Antibacterial Agent against Multidrug-Resistant Staphylococcus aureus by Targeting Cell Membrane

Jinlian Huang, Zhichao Xu, Peikun He, Zhiwei Lin, Renhai Peng, Zhijian Yu, Peiyu Li, Qiwen Deng, Xiaoju Liu

Current Microbiology · 2025

DOI: 10.1007/s00284-024-04001-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Microbiology, 2025. Verfasst von Jinlian Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, Guangdong, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Biofilms, Microbial Sensitivity Tests, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infections and antimicrobial resistance are becoming serious global public health crises. Multidrug-resistant Staphylococcus aureus (S. aureus) infections necessitate novel antimicrobial development. In this study, we demonstrated TAK-285, a novel dual HER2/EGFR inhibitor, exerted antibacterial activity against 17 clinical methicillin-resistant S. aureus (MRSA) and 15 methicillin sensitive S. aureus (MSSA) isolates in vitro, with a minimum inhibitory concentration (MIC) of 13.7 μg/mL. At 1 × MIC, TAK-285 completely inhibited the growth of S. aureus bacterial planktonic cells, and at 2 × MIC, it exhibited a superior inhibitory effect on intracellular S. aureus SA113-GFP compared to linezolid. Moreover, TAK-285 effectively inhibited biofilm formation at sub-MIC, eradicated mature biofilm and eliminated bacteria within biofilms, as confirmed by CLSM. Furthermore, the disruption of cell membrane permeability and potential was found by TAK-285 on S. aureus, suggesting its targeting of cell membrane integrity. Global proteomic analysis demonstrated that TAK-285 disturbed the metabolic processes of S. aureus, interfered with biofilm-related gene expression, and disrupted membrane-associated proteins. Conclusively, we repurposed TAK-285 as an antimicrobial with anti-biofilm properties against S. aureus by targeting cell membrane. This study provided strong evidence for the potential of TAK-285 as a promising antimicrobial agent against S. aureus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBiofilmsMicrobial Sensitivity TestsMethicillin-Resistant Staphylococcus aureusCell MembraneDrug RepositioningHumansStaphylococcus aureusStaphylococcal InfectionsDrug Resistance, Multiple, Bacterial

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, Guangdong, China.
  • Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Huazhong University of Science and Technology Union Shenzhen Hospital, No. 89 Taoyuan Road, Nanshan District, Shenzhen, 518052, Ch…
  • School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, Guangdong, China. qiwendeng@hotmail.com.

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Huang, J., Xu, Z., He, P., Lin, Z., Peng, R., Yu, Z., Li, P., Deng, Q., & Liu, X. (2025). Repurposing TAK-285 as An Antibacterial Agent against Multidrug-Resistant Staphylococcus aureus by Targeting Cell Membrane. Current Microbiology. https://doi.org/10.1007/s00284-024-04001-3

Vancouver

Huang J, Xu Z, He P, Lin Z, Peng R, Yu Z, et al. Repurposing TAK-285 as An Antibacterial Agent against Multidrug-Resistant Staphylococcus aureus by Targeting Cell Membrane. Current Microbiology. 2025. doi:10.1007/s00284-024-04001-3

BibTeX
@article{Huang2025,
  author = {Huang, Jinlian and Xu, Zhichao and He, Peikun and Lin, Zhiwei and Peng, Renhai and Yu, Zhijian and Li, Peiyu and Deng, Qiwen and Liu, Xiaoju},
  title = {Repurposing TAK-285 as An Antibacterial Agent against Multidrug-Resistant Staphylococcus aureus by Targeting Cell Membrane},
  journal = {Current Microbiology},
  year = {2025},
  doi = {10.1007/s00284-024-04001-3}
}
Kostenlos starten →